RHHBY ROCHE HOLDING AG
- 36.240
- +0.510+1.43%
ROCHE HOLDING AG News
Intron Health Lifts Price Target on Roche Holding AG
Roche Holding AG Rises Thursday
Roche Signs Digital Pathology MoU in Egypt
Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Lower On Wednesday?
Barclays Remains a Hold on Roche Holding AG (RHHVF)
Why This Gene-Therapy Company's Stock Is Rising 228% -- Barrons.com
Roche to Acquire CAR-T Cell Therapy Focused Poseida for $1.5B
Roche's Proposed Acquisition Of Poseida Therapeutics Poised To Establish New Core Capability In Cell Therapy For Cancer And Autoimmune Diseases: Details
Roche Holding AG (RHHVF) Receives a Sell From Goldman Sachs
Roche Anti-TIGIT Therapy Fails to Extend Survival in Late-stage Lung Cancer Trial
Poseida Therapeutics to Be Acquired by Roche Holdings in $1.5 Billion Deal
Roche's Lung-Cancer Trial Failure Doesn't Surprise -- Market Talk
Roche's Genentech Provides Update On SKYSCRAPER-01 Phase III Study In PD-L1-High NSCLC Patients
Poseida Therapeutics To Be Acquired BB Roche In $1.5B Deal, Stockholders To Receive Up To $13/ Share In Cash
Roche: Transaction Is Expected Closed in 1Q 2025
Roche: Stockholders Would Also Get a Non-Tradeable Contingent Value Right
Roche's Combination Formulation for Non-small Cell Lung Cancer Falls Short of Primary Endpoint
Roche: Agreement Represents a Total Equity Value of Approximately $1.0B
Roche: Agreement Includes Cell Therapy Candidates and Related Platform Technologies
Press Release: Poseida Therapeutics, Inc. Announces Agreement to Be Acquired by Roche Holdings, Inc.
Analysis
Price Target
No Data
No Data
